vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and REGIS CORP (RGS). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $57.1M, roughly 1.3× REGIS CORP). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 22.3%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $891.0K). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 7.8%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
REGIS CORPRGSEarnings & Financial Report
Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.
PBYI vs RGS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $57.1M |
| Net Profit | — | $456.0K |
| Gross Margin | 69.3% | — |
| Operating Margin | 22.7% | 10.8% |
| Net Margin | — | 0.8% |
| Revenue YoY | 27.7% | 22.3% |
| Net Profit YoY | — | -94.0% |
| EPS (diluted) | $0.26 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $57.1M | ||
| Q3 25 | $54.5M | $59.0M | ||
| Q2 25 | $52.4M | $60.4M | ||
| Q1 25 | $46.0M | $57.0M | ||
| Q4 24 | $59.1M | $46.7M | ||
| Q3 24 | $80.5M | $46.1M | ||
| Q2 24 | $47.1M | $49.4M | ||
| Q1 24 | $43.8M | $49.2M |
| Q4 25 | — | $456.0K | ||
| Q3 25 | $8.8M | $1.4M | ||
| Q2 25 | $5.9M | $116.5M | ||
| Q1 25 | $3.0M | $250.0K | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | $20.3M | $-853.0K | ||
| Q2 24 | $-4.5M | $91.2M | ||
| Q1 24 | $-4.8M | $-2.3M |
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
| Q4 25 | 22.7% | 10.8% | ||
| Q3 25 | 17.6% | 10.0% | ||
| Q2 25 | 12.7% | 12.1% | ||
| Q1 25 | 8.7% | 8.8% | ||
| Q4 24 | 22.6% | 11.8% | ||
| Q3 24 | 27.4% | 4.6% | ||
| Q2 24 | -4.6% | — | ||
| Q1 24 | -5.3% | 8.3% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | 16.2% | 2.3% | ||
| Q2 25 | 11.2% | 192.9% | ||
| Q1 25 | 6.5% | 0.4% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | 25.2% | -1.9% | ||
| Q2 24 | -9.6% | 184.7% | ||
| Q1 24 | -11.0% | -4.7% |
| Q4 25 | $0.26 | $0.16 | ||
| Q3 25 | $0.17 | $0.49 | ||
| Q2 25 | $0.12 | $43.67 | ||
| Q1 25 | $0.06 | $0.08 | ||
| Q4 24 | $0.40 | $2.71 | ||
| Q3 24 | $0.41 | $-0.36 | ||
| Q2 24 | $-0.09 | $38.40 | ||
| Q1 24 | $-0.10 | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $18.4M |
| Total DebtLower is stronger | $22.7M | $113.3M |
| Stockholders' EquityBook value | $130.3M | $188.7M |
| Total Assets | $216.3M | $588.3M |
| Debt / EquityLower = less leverage | 0.17× | 0.60× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $18.4M | ||
| Q3 25 | $94.4M | $16.6M | ||
| Q2 25 | $96.0M | $17.0M | ||
| Q1 25 | $93.2M | $13.3M | ||
| Q4 24 | $101.0M | $10.2M | ||
| Q3 24 | $96.7M | $6.3M | ||
| Q2 24 | $96.8M | $10.1M | ||
| Q1 24 | $107.2M | $5.9M |
| Q4 25 | $22.7M | $113.3M | ||
| Q3 25 | $34.0M | $111.3M | ||
| Q2 25 | $45.3M | $110.8M | ||
| Q1 25 | $56.7M | $112.0M | ||
| Q4 24 | $68.0M | $111.5M | ||
| Q3 24 | $79.3M | $95.2M | ||
| Q2 24 | $90.7M | $99.5M | ||
| Q1 24 | $102.0M | $179.7M |
| Q4 25 | $130.3M | $188.7M | ||
| Q3 25 | $115.3M | $187.6M | ||
| Q2 25 | $104.7M | $185.6M | ||
| Q1 25 | $97.1M | $68.6M | ||
| Q4 24 | $92.1M | $66.7M | ||
| Q3 24 | $71.1M | $56.4M | ||
| Q2 24 | $48.5M | $56.8M | ||
| Q1 24 | $51.0M | $-35.8M |
| Q4 25 | $216.3M | $588.3M | ||
| Q3 25 | $202.9M | $592.1M | ||
| Q2 25 | $194.9M | $599.0M | ||
| Q1 25 | $196.2M | $511.2M | ||
| Q4 24 | $213.3M | $530.1M | ||
| Q3 24 | $220.7M | $508.9M | ||
| Q2 24 | $205.0M | $530.5M | ||
| Q1 24 | $214.1M | $543.7M |
| Q4 25 | 0.17× | 0.60× | ||
| Q3 25 | 0.30× | 0.59× | ||
| Q2 25 | 0.43× | 0.60× | ||
| Q1 25 | 0.58× | 1.63× | ||
| Q4 24 | 0.74× | 1.67× | ||
| Q3 24 | 1.12× | 1.69× | ||
| Q2 24 | 1.87× | 1.75× | ||
| Q1 24 | 2.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $1.7M |
| Free Cash FlowOCF − Capex | $14.4M | $891.0K |
| FCF MarginFCF / Revenue | 19.1% | 1.6% |
| Capex IntensityCapex / Revenue | 0.0% | 1.4% |
| Cash ConversionOCF / Net Profit | — | 3.65× |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | $14.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $1.7M | ||
| Q3 25 | $9.7M | $2.3M | ||
| Q2 25 | $14.1M | $6.8M | ||
| Q1 25 | $3.6M | $6.2M | ||
| Q4 24 | $15.6M | $2.1M | ||
| Q3 24 | $11.0M | $-1.3M | ||
| Q2 24 | $1.0M | $5.1M | ||
| Q1 24 | $11.2M | $-277.0K |
| Q4 25 | $14.4M | $891.0K | ||
| Q3 25 | $9.7M | $1.9M | ||
| Q2 25 | $14.1M | $6.2M | ||
| Q1 25 | $3.6M | $5.9M | ||
| Q4 24 | $15.6M | $1.7M | ||
| Q3 24 | $11.0M | $-1.4M | ||
| Q2 24 | $1.0M | $5.1M | ||
| Q1 24 | — | $-326.0K |
| Q4 25 | 19.1% | 1.6% | ||
| Q3 25 | 17.7% | 3.2% | ||
| Q2 25 | 26.8% | 10.3% | ||
| Q1 25 | 7.7% | 10.3% | ||
| Q4 24 | 26.4% | 3.6% | ||
| Q3 24 | 13.7% | -3.0% | ||
| Q2 24 | 2.1% | 10.3% | ||
| Q1 24 | — | -0.7% |
| Q4 25 | 0.0% | 1.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.0% | 0.9% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.1% |
| Q4 25 | — | 3.65× | ||
| Q3 25 | 1.10× | 1.68× | ||
| Q2 25 | 2.41× | 0.06× | ||
| Q1 25 | 1.21× | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBYI
Segment breakdown not available.
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
